CNR1 and chronic kidney disease: In an experimental model of chronic kidney disease, the expression of pro-fibrotic factors such as collagen α1, TGF-β1 precursor, and α-SMA were evidently reduced in myocardium after the pharmacological blockade of CB1 [40].